Home>Topics>Stocks>Roche Holding AG ADR

Roche Holding AG ADR RHHBY

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Roche Reaffirms Full Year Outlook But Suffers From Currency Movements

      Headlines

      Wed, 16 Apr 2014

      By Trefis : Roche Holdings (OTC: RHHBY ) recently released its Q1 2014 results and reported a slight decline of 1% in its revenues. However, this decline is primarily

    2. Counterfeit Herceptin finds its way into European supply chain

      Headlines

      Wed, 16 Apr 2014

      Vials from nine batches of Roche's ( OTCQX: RHHBY ) top-selling drug allegedly stolen in Italy have been tampered with and reintroduced into the European market. Adulterated

    3. Roche's CEO Discusses Q1 2014 Results - Earnings Call Transcript

      Headlines

      Tue, 15 Apr 2014

      Roche Holding Ltd ADR ( OTCQX: RHHBY ) Q1 2014 Results Earnings Conference Call April 15, 2014 8:00 AM ET Executives Dr. Severin Schwan, Chief Executive Officer

    4. EMA finishes its examination of Roche

      Headlines

      Mon, 14 Apr 2014

      The European Medicines Agency concludes its inquiry into Roche's ( OTCQX: RHHBY +2% ) drug safety reporting. The firm allegedly under-reported adverse events for 19 of its drugs. It sends its findings

    5. Roche's Competitive Advantage

      Headlines

      Thu, 10 Apr 2014

      By Trefis : Roche Holdings ( OTCQX: RHHBY ) has managed to grow its revenues and earnings at an impressive rate, whereas other big pharmaceutical firms have suffered due

    6. Hospira wins U.K. patent suit

      Headlines

      Thu, 10 Apr 2014

      London's High Court rules Roche's ( OTCQX: RHHBY -0.7% ) 115 and 455 Herceptin patents are invalid paving the way for Hospira ( HSP -3.5% ) to market a biosimilar version

    7. French plan to allow generics alarms Big Pharma

      Headlines

      Thu, 10 Apr 2014

      generics. Substitutions only apply to retail pharmacies. 40% of biotech prescriptions are filled in hospitals. ( OTCQX: RHHBY ) ( AMGN ) ( NVS ) ( SNY ) ( LLY ) ( PFE ) ( BMY ) ( MRK ) ( GSK ) ( JNJ ) ( HSP ) ( ABBV ) ( AZN ) ( OTCPK:BAYRY ) Post your

    8. Research group says governments are wasting $ on flu drug stockpiles

      Headlines

      Thu, 10 Apr 2014

      from the research network the Cochrane Review doubt the wisdom of governments spending billions stockpiling Roche's ( OTCQX: RHHBY ) flu drug Tamiflu. Based on their review of the data, they conclude the only benefit is a half day reduction in flu symptoms

    9. Critical Shortage Of Injectables Create Opportunity For Drugmakers

      Headlines

      Wed, 9 Apr 2014

      By Kapitall : Of the 65 drug shortages listed by the Food and Drug Administration, more than 40 are of the generic sterile injectable variety. Nitroglycerin, used intravenously to treat hypertension and assorted heart conditions, is one of those drugs. Last year, two manufacturers -- Hospira ( HSP

    10. Clinical diagnostics leader extends alliance

      Headlines

      Wed, 9 Apr 2014

      Roche ( OTCQX: RHHBY ) and Hitachi High-Technologies Corporation renew their partnership with a 10-year contract to jointly develop and manufacture

    « Prev12345Next »
    Content Partners